Primary angioplasty or thrombolysis?a topical parable

Bogaty, Peter; Brophy, James M.
May 2004
BMJ: British Medical Journal (International Edition);5/22/2004, Vol. 328 Issue 7450, p1257
Academic Journal
Debates the use of angioplasty versus thrombolysis in the management of acute myocardial infarction. Presentation of a fictional history of the treatment of myocardial infarction; Discovery that streptokinase, a bacterial enzyme, could dissolve human blood clots; Comparison of throbolysis to primary angioplasty.


Related Articles

  • Primary angioplasty should be first line treatment for acute myocardial infarction. Smith, David; Channer, Kevin // BMJ: British Medical Journal (International Edition);5/22/2004, Vol. 328 Issue 7450, p1254 

    Presents a medical debate regarding primary angioplasty as a first line treatment for acute myocardial infarction. Relation between normal coronary artery blood flow and mortality after myocardial infarction; Comparison of the methods thrombolysis and coronary angioplasty for restoring blood flow.

  • Primary percutaneous coronary intervention in acute myocardial infarction: time, time, and time! Steg, P. G.; Juliard, J-M. // Heart;Aug2005, Vol. 91 Issue 8, p993 

    Focuses on the impact of time and delays on the outcome after primary percutaneous coronary intervention (PCI). Relationship between delay between admission and actual inflation of the PCI balloon in the coronary arteries and patient mortality; Decrease in the benefits of intravenous...

  • Reduced In-Hospital Mortality Following Intracoronary Streptokinase Treatment of Acute Myocardial Infarction. Salem, Bakr I.; Gowda, Siddhesh; Haikal, Maged // Vascular Surgery;May/Jun1987, Vol. 21 Issue 3, p215 

    Reduced short-term mortality following thrombolytic treatment of acute myocardial infarction has been reported by earlier studies. This study was performed to compare data from our institution with such results. From January, 1984, through January, 1986, a total of 628 consecutive patients were...

  • Patients with acute MI should be transferred for angioplasty. Fitzsimmons, Anne; Lindbloom, Erik J. // Journal of Family Practice;Dec2003, Vol. 52 Issue 12, p940 

    This study showed that angioplasty within two hours of presentation for acute myocardial infarction (MI) is superior to thrombolysis, primarily due to a lower reinfarction rate. This is true whether a patient presents to a healthcare facility with angioplasty capability or one that transfers a...

  • Delay in presentation after myocardial infarction. Heriot, Alexander G.; Brecker, Stephen J.; Coltart, D. John // Journal of the Royal Society of Medicine;Nov1993, Vol. 86 Issue 11, p642 

    Thrombolytic therapy reduces mortality in acute myocardial infarction (AMI), giving maximal benefit with early treatment. In the UK delayed presentation after AMI may reduce the advantages of thrombolysis. To assess this, 103 patients presenting with AMI to two London Hospitals were interviewed...

  • Rising to the challenge: transforming the treatment of ST-segment elevation myocardial infarction. Ghali, William A.; Donaldson, Cameron R.; Knudtson, Merril L.; Lewis, Steven J.; Maxwell, Colleen J.; Tu, Jack V. // CMAJ: Canadian Medical Association Journal;7/8/2003, Vol. 169 Issue 1, p35 

    The treatment of ST-segment elevation myocardial infarction has undergone profound changes since the bedrest era of the 1960s. Most recently, the use of percutaneous coronary intervention (PCI) has been shown to be superior to thrombolysis. However, to be effective, PCI must be done as soon as...

  • National service framework for coronary heart disease: audit of English hospitals. Rhodes, Michelle; Newman, Christopher; Read, Susan // BMJ: British Medical Journal (International Edition);3/23/2002, Vol. 324 Issue 7339, p709 

    Reports on a study which audited the delivery of thrombolysis in all acute hospitals in England. National service framework for coronary heart disease which gives priority to reducing delays in the delivery of thrombolysis for acute myocardial infarction; Methods; Results; Indication of...

  • Should primary angiopblasty available for all patients with an ST elevation myocardial infarction? de Belder, A // Heart;Dec2005, Vol. 91 Issue 12, p1509 

    The article discusses the importance of making primary angioplasty available for all patients with an ST elevation myocardial infarction (STEMI). For the acute myocardial infarction patient, percutaneous coronary intervention is clearly superior to thrombolysis for many clinical end points, yet...

  • Feasibility and safety of thrombectomy with TVAC aspiration catheter system for patients with acute myocardial infarction. Yokoyama, Jin; Kushibiki, Motoi; Fujiwara, Takayuki; Tamura, Yujin; Maeda, Naotaka; Higuma, Takumi; Sasaki, Shingo; Yoshimachi, Fuminobu; Matsunaga, Toshiro; Hanada, Hiroyuki; Osanai, Tomohiro; Okumura, Ken // Heart & Vessels;Jan2006, Vol. 21 Issue 1, p1 

    Early reperfusion with angioplasty and stenting is established as a central, effective treatment for acute myocardial infarction (AMI). The role of thrombectomy prior to angioplasty remains to be elucidated. To evaluate its feasibility, safety, and efficacy, thrombectomy using a TVAC aspiration...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics